Abstract Details
|
Andrew Russman, DO, FAAN
(Cleveland Clinic)
PRESENTER |
Dr. Russman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific Corporation. Dr. Russman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Russman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. |
| Maurice M. Ohayon, MD, PhD, DSc (Stanford) | The institution of Dr. Ohayon has received research support from Jazz pharmaceuticals. The institution of Dr. Ohayon has received research support from Takeda Pharmaceuticals. |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| Daniel Burke | No disclosure on file |
| Susan M. Linder (Cleveland Clinic, Biomedical Eng.) | No disclosure on file |
| Jay L. Alberts, PhD (Cleveland Clinic) | Dr. Alberts has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ceraxis. Dr. Alberts has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceraxis. The institution of Dr. Alberts has received research support from NIH. The institution of Dr. Alberts has received research support from Department of Defense. The institution of Dr. Alberts has received research support from Michael J. Fox Foundation. Dr. Alberts has received intellectual property interests from a discovery or technology relating to health care. Dr. Alberts has received personal compensation in the range of $500-$4,999 for serving as a Member, Health and Wellness Council with Peloton Interactive. |